|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Advanced Viral Research Corp., of Yonkers, N.Y., received net proceeds of $862,500 after selling $1 million of its 5 percent convertible debentures, due April 28, 2008. The buyer, Cornell Capital Partners, also committed to purchase an additional $500,000 of convertible debentures at par within 10 business days of the filing of a registration statement with the SEC, and another $1 million of convertible debentures at par within 20 business days from the date the registration statement is declared effective. Advanced Viral also received gross proceeds of $826,000 in exchange for the private sale of 10,325,000 common shares at 8 cents per share, and warrants to purchase ...